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Abstract
This review considers the knowledge on the colonization of the infant’s gut with 
beneficial bacteria starting from early days of life. This colonization drives the de-
veloping, but immature, immune system of the infant through the local, intestinal, 
well-regulated, immune mechanisms, to tolerogenic immune response and “no-
disease” state. This response is characterized by TH1 predominance. Any pertur-
bation of this homeostasis by environmental factors such as antibiotics, “swings 
back” the immune response towards TH2 response, increasing the propensity to 
develop allergic inflammation, and clinical allergic diseases. There is emerging evi-
dence to support the role of intestinal microbiota in developing allergic disease.
At clinical level, there is vivid research to determine role of antibiotics exposure 
in developing allergic diseases such as asthma, allergic rhinitis, eczema, and food 
allergy. The results of studies appear as if they are inconsistent or even conflicting. 
However, this inconsistency seems to be related to some methodological factors in 
evaluating the host, exposure, outcome and confounders. Still, there is clear evi-
dence that antibiotic exposure during prenatal period, infancy, or early childhood is 
associated with high risk of allergic diseases and asthma during infancy, childhood 
or early adolescence. This risk is governed by individual’s genetic background & 
place of residence, type and dose of antibiotics. It is quite important to remember, 
that antibiotics exposure or use is only one of the risk factors of increased risk of 
allergy among children and does not exclusively account for this rise. 
Introduction
Allergic diseases are chronic, non-infectious, immune-me-
diated diseases [1]. Among them, of major concern, are 
asthma, allergic rhinitis and atopic dermatitis. They are more 
common among children than adults. It is estimated that 
respiratory allergic diseases (asthma, allergic rhinitis) alone 
affect 700 million individuals in the world [2]. It is notice-
able that their prevalence during the last decades had been 
increasing, but at different rates, in various regions of the 
world [2-3]. Currently, asthma is the most common chronic 
childhood condition [3]. In some developed countries the 
prevalence of asthma reached 35-40 %, whereas it is less 
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than 5% in many developing countries [4]; and asthma is still 
increasing in many low- and middle-income countries [3, 5].
Allergic diseases exert a tremendous impact on affected indi-
viduals, their families, and societies. They affect the quality of 
life, increase risk of comorbid conditions, and risk of death, as 
in asthma [2, 6]. In addition, the economic burden of these 
diseases is substantial. It is related to considerable direct 
medical cost (physician’s visits, emergency department vis-
its, hospital admissions, laboratory and radiological workup, 
therapy… etc.) and indirect medical cost (frequent absences 
from work or school, reduced productivity, impaired school 
performance ... etc.) [2, 6, 7]. The fact that these diseases are 
of high prevalence and chronic, the annual economic impact 
considerable. For example, makes the total cost of asthma 
had been estimated to be about £2.5 billion in UK [2]. In USA, 
between 2002 to 2007, the annual economic cost of asthma 
was $56.0 billion; direct medical costs were $50.1 billion and 
indirect costs were $5.9 billion [8]. 
This prompted extensive research to identify the risk factors 
and “origin “of asthma. Allergic diseases, including asthma, 
do not follow simple Mendelian inheritance but they result 
from the interplay of multiple genetic and interacting environ-
mental factors [9]. Risk factors for development of asthma are 
numerous, including infectious agents (respiratory syncytial 
virus, human rhinoviruses, chlamydophila, and mycoplasma), 
allergen exposure (pollens, house dust mites, indoor pets, and 
molds), exposure to pollutants (tobacco smoke exposure, die-
sel exhaust, gases,) and medication exposure [10-12]. These 
factors work, singly or in combination, at critical “window-
time” while infant’s immune system is still developing. 
Microbial colonization of infant’s gut
Newborn’s initial exposure to the microbes and gut coloniza-
tion begin at time of birth and continue during infancy. The 
development of microbial flora is determined by the density 
or load (inoculum) of the first maternal microbiota, mode 
of delivery (vaginal delivery vs. caesarian section delivery), 
feeding practices (breast feeding vs. formula feeding), and 
antimicrobial use [13-15]. The type of maternal intestinal mi-
crobiota has its clear influence on the type of microbiota 
colonizing infant’s intestine (16). This effect is not limited to 
the first month of life but it extends for the first few months 
of infant’s life [16]. 
Infants delivered by caesarian section have been reported to 
harbor microbiota that is different from that seen in vaginally 
delivered infants, both in the timing of colonization and the 
composition of microbiota [14]. When compared to vaginally 
delivered infants, they take up to one month before similar 
numbers of bacteria are present, and higher numbers and 
prevalence of Clostridium species, Klebsiella species, Entero-
bacteriaceae [14, 17-18]. They are also colonized by Bacte-
roides species, Bifidobacterium and E. coli [17]. Interestingly, 
perturbation in the composition of intestinal flora of cesarean 
section infants last up to at least 6 months of age [19]. Risk of 
development of atopy, asthma, and allergic rhinitis is higher 
cesarean section infants [20] possibly due to deviations from 
in normal gut colonization with maternal flora. 
In healthy breast-fed infants, Bifidobacterium constitute 60-
70% of the gut microbiota (with predominance of B. longum, 
B infantis, and B. breve species) compared with formula-fed 
infants, where Bacteroides, Clostridium and Enterobacteria-
ceae predominate [14, 18]. Alterations in composition of in-
testinal microbial composition that leads to reduced bacterial 
load of Bifidobacterium species or predominance of more 
diverse non-beneficial microbiota have been associated with 
risk of allergies and infections [21] and other diseases [22]. 
Intestinal microbiota and atopic diseases
Although gut colonization is complete by age of one week, it 
takes few months for the bacterial species and numbers to be-
come steadily consistent [14, 21]. This relative instability makes 
the gut colonization with intestinal flora liable to changes 
with negative impact on infant’s health. The composition of 
intestinal microflora differs between atopic and healthy in-
fants [17]. Atopic children have lower counts of lactobacillus, 
bifidobacteria and Bacteroides Species. In a large study on 
957 Dutch infants, using real-time PCR on stool samples, the 
presence of C. difficle was associated with increased risk of 
recurrent wheeze, atopic dermatitis and atopic sensitization 
at age of 2 years [23]. Multiple clinical trials on oral adminis-
tration of probiotic bacteria (Lactobacillus or Bifidobacteria) 
to the pregnant women or to the pregnant women and their 
infants indicate that they reduce risk of allergic diseases es-
pecially atopic dermatitis [24, 25]. Breast milk constitutes a 
major source of support to gut colonization by providing a 
large amount of galacto-oligosaccharides, which selectively 
accelerate the growth of bifidobacteria [26] and also it con-
tains Bifidobacteria [27]. Multiple, recent, large, epidemiologi-
cal studies confirmed the beneficial effects of breast feeding 
on reducing the risk of asthma, allergic rhinitis, and atopic 
eczema among children [28-30]. 
Infant’s intestinal microbiota and immune 
response
In newborn, in addition to its important role in nutrition and 
metabolism, the gut microbiota functions in promoting and 
maintaining mucosal immune system, both in terms of its 
physical factors and function, and maintaining a very well-
balanced immune response. Gut-associated mucosal lym-
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phoid tissue (GALT) becomes reactive to pathogenic bacteria 
but tolerant to “beneficial” bacteria. Intestinal microbiota 
play an important role in development of tolerogenic DC 
from the mesenteric lymph nodes of the GALT and instru-
mental in production of secretory IgA.
Intestinal epithelium expresses various pathogen recogni-
tions receptors (PRRs) including Toll-like receptors (TLRs) and 
nucleotide-binding oligomerization domain-like receptors 
(NLRs) that activate immune response against pathogens. 
Since pathogenic bacteria and gut commensals express many 
of these pathogen-associated molecular patterns (PAMPs) 
there is a tight control on immune response mechanisms so 
that it will recognize and specifically respond to pathogens 
but remain, at same time, tolerant to commensals. These 
mechanisms involve intestinal epithelial cells (IECs), their TLRs, 
dendritic cells (DC), and Treg cells [31].
 
It is known that TH2 cells characterized by their production 
of IL-4, IL-5, IL-9 and IL-13 contribute to the development of 
and maintenance of allergic inflammatory process while TH1 
cells by producing tumor necrosis-α (TNF-α) and interferon- γ 
(IFN-γ) modulate cell-mediated immunity. T-regulatory (Treg) 
cells with their immunomodulatory or immunosuppressive 
capability maintain immunological tolerance, and are key 
players in regulating immune response in non-disease states 
[31]. Deviations from this, in term of Treg numbers or func-
tions, is associated with development of allergic disease 
(Fig. 1). At birth, the neonate’s immature immune response 
is skewed towards TH2-like response. The microbial coloniza-
tion of the gut stimulates the development of TH1 cells. The 
microbial strain (commensal or pathogenic) of the gut has an 
important role (through microbial PAMPs with gut cells-TLRs/
NLR interactions) in modulating both intestinal innate and 
adaptive immune responses. Basic animal studies on germ-
free (GF) mice revealed that in absence of microbial coloni-
zation, T-cells produced more TH2 cytokines. This TH2-cell 
predominance was corrected with colonization of GF mice 
with B. fragilis alone, promoted TH1 response, and restored 
the TH1/TH2 imbalance [32]. 
Evidence from clinical studies also demonstrated that pro-
biotic bacteria reduced TH2 cytokine pattern while promot-
ing TH1 response [33]. The intestinal microbiota has marked 
immunomodulatory effects that are essential in maintaining 
an immune tolerance. Dietary and environmental (e.g. anti-
biotics) factors can modulate the intestinal microbiota and 
thus capable of influencing immune response towards allergic 
diseases and asthma development. 
Antibiotics use and allergy risk: any evidence?
Worldwide, antibiotic prescriptions for outpatient use espe-
cially in children are usually high. This varies from one country 
to another [34], and even across the same country it is not 
uniform [35]. Antibiotics are frequently and commonly inap-
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Fig. 1.  In healthy subjects, beneficial gut 
flora stimulates the development 
of tolerance state (through 
intraintestinal epithelial cells and 
dendritic cells and their surface 
markers) leading to balanced 
TH1/TH2 response. Alterations 
(e.g. by antibiotics) disrupts this 
microbiota, immune tolerance, and 
induces allergic response.
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propriately prescribed in the treatment of upper respiratory 
tract infections in children [36]. It was noticed that there was a 
correlation between high antibiotics use and development of 
microbial resistance [37]. It is logical that the observed parallel 
increase in antibiotic use and the rise in asthma prevalence 
would prompt research to test any causal relationship [38]. 
Sources of inconsistent clinical evidence
Numerous epidemiological studies have addressed the pos-
sible association between antibiotics during early infancy 
and development of allergic diseases. The reported results of 
these studies seem to be inconsistent or even conflicting. The 
reasons for discrepancies in the results could be attributed to 
the following methodological differences in evaluating the 
outcome, exposure and the host (Table 1):
1)  Factors related to the subjects (hosts) under study. 
These include:
a.  Age of individuals at time of exposure: the chronological 
time of an antibiotic exposure in a particular study is dif-
ferent from another study. One finds that in various studies 
there is a broad-spectrum of exposure time including ex-
posures at some perinatal or neonatal period, while in oth-
ers during the first 1, 3, 6 months, first year or even later.
b.  Genetic background of individuals: some studies recruited 
only high-risk (positive family of allergic diseases in at least 
one parent or one sibling children). Generally, these stud-
ies showed weak or even no association between anti-
biotic use and allergy development. In studies that were 
conducted on children with no risk of allergy, the associa-
tion was more evident. 
c.  Place of residence: studies conducted on children living in 
urban areas showed weak or no association compared to 
those done on children living in rural areas. 
2) Factors related to allergic diseases (outcome):
a.  Heterogeneity of allergic diseases where these include 
asthma, recurrent wheeze, atopic dermatitis (eczema), al-
lergic rhinitis, cow’s milk allergy.
Subject (host) factors:
a. Age of subject at antibiotic exposure: prenatal, perinatal, neonatal, first 6 month, etc.
b. Genetic background: e.g. presence or absence of family history of allergies.
c. Place of residence: e.g. urban vs. rural.
Disease (outcome) factors:
a. Heterogeneity of allergic diseases: e.g. asthma, eczema, food allergy, or wheeze.
b. Disease phenotypes: some allergic disease have several phenotypes: e.g. early wheeze, late wheeze, or persistent wheeze. 
c. Validation of allergy diagnosis: e.g. physician-diagnosed allergy, questionnaire-based diagnosis, or laboratory–confirmed diagnosis.
d. Variation of etio-pathology of allergies: presence of major non-immune mediated mechanisms: e.g. filaggrin in atopic dermatitis, matrix metalloproteinase in asthma, “leaky gut” in food allergy.
e. Timing of development of the allergic disease: e.g. age of 2, 4, 6, 13 years, or even adulthood.
Factors related to antibiotics (exposure):
a. Spectrum of coverage: broad- vs. narrow-spectrum antibiotics.
b. Classes or combinations of antibiotics; e.g. penicillins, or cephalosporins.
Study design-related factors:
a. Study type: e.g. Prospective, retrospective, case control.
b. Sample size: e.g. large, medium or small.
Other factors:
a. Co-existent dietary factors: e.g. vitamin D
b. Medications: e.g. Paracetmol.
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b.  Some allergic diseases have several phenotypes as the case 
in wheeze or asthma. It is now known that ‘‘asthma’’ is an 
all-encompassing term for several disease phenotypes each 
triggered by different etiologic factor [39]. For example, 
wheeze phenotypes in preschool children include never/ 
infrequent, transient early, prolonged early, intermediate 
onset, late onset and persistent wheeze [40]. Studies tak-
ing “asthma” as an outcome measure without taking in 
consideration these phenotypes may fail to show associa-
tion between antibiotics and use this allergic disease.
c.  Validation of diagnosis: in various studies the outcome 
measure was reached differently. For example, in some 
studies diagnosis of asthma was made by physician, while 
in others by questionnaire, or confirmed by laboratory 
tests. In others, the outcome was allergic sensitization 
(only lab diagnosis of tendency to allergy not necessarily 
associated with clinical manifestations [41]), which is dif-
ferent from allergy disease (clinical diagnosis).
d.  Variation of etio-pathology of allergic diseases. Although 
these diseases share that they are immune-mediated, 
there are other non-immunological defects involved of 
pivotal role in disease etiology. For example, there is in-
creasing evidence on the role of epithelial-barrier distur-
bance due to filaggrin defects [42] or lipid metabolism 
abnormalities in atopic dermatitis [43]; or matrix metal-
loproteinase/extracellular matrix in asthma [44]. These are 
not immune-mediated mechanisms and unlikely to be re-
lated to intestinal microbiota or modified by antibiotics. 
e.  Timing of the allergic disease: in some studies the oc-
currence of allergic diseases was evaluated at age of 2-3 
years, while in other at 5-6 years or even later at adult-
hood. 
3) Factors related to antibiotics:
a.  Factors related to antibiotics: the antibiotic spectrum is dic-
tated by type of infection in these children (e.g. neonatal 
sepsis versus upper respiratory tract infection). It also is 
governed by the timing of exposure, i.e. prenatal (e.g. ma-
ternal urinary tract infection), natal neonatal (e.g. neonatal 
sepsis), or first few months of infants life. Based on this, 
some studies evaluated broad-spectrum antibiotics, while 
others narrow-spectrum antibiotics, and their relationship 
to risk of allergies.
b.  Different studies evaluated the association with different 
combinations of classes of antibiotics: e.g. macrolides, 
penicillins, cephalosporins, etc. 
4) Factors related to study designs:
a.  Study types: some studies were retrospective while others 
were prospective, case-controls, or cross-sectional. There 
are strengths and limitations inherent with each study de-
sign. The strength of association varied by the type of the 
study [45-47]. 
b.  Sample size of children enrolled in these studies varied. It 
has its detrimental effect on the presence of absence or 
the strength of association between antibiotic exposure 
and development of allergies. 
5) Other confounders:
In these studies, the possibility of other co-existing confound-
ing factors was not explored apart from simultaneous use of 
paracetamol with antibiotics [48-49]. There is emerging evi-
dence that vitamin D deficiency during prenatal period [50], 
or during childhood is associated with asthma [51].
Clinical studies on the association
Since prenatal exposure to environmental factors such as to-
bacco smoke exposure [52], Mediterranean diet [53], mater-
nal stress [54], or pets [55] have been shown to increase risk 
of childhood allergies, research tried to determine if antibiotic 
has similar effect. Basic research on murine models treated 
prenatally (during 21 days of uterine life) with antibiotics 
affected mice intestinal microbiota, immune response and 
risk of asthma [56]. Mouse models exposed during neonatal 
period to vancomycin or streptomycin (including in utero pe-
riod) developed experimental allergic asthma while animals 
exposed during adulthood did not [57]. Bronchoalveolar 
lavage showed increase of inflammatory cells, eosinophils 
counts and IgE. This asthma induction in vancomycin treated 
neonatal mice was associated with reduction in total bacteria 
in stool pellets, marked shift and reduced diversity of gut mi-
crobiota. In addition, there was reduction in Treg cells in the 
colon, but not in the lungs, of these newborn animals [57]. 
Prenatal exposure 
Clinical studies on the association between indirect antibiotic 
exposure (during uterine life or lactation period) and allergic 
diseases showed increased risk for allergic diseases among 
children. In a large prospective birth cohort, a significantly 
positive association was demonstrated between prenatal 
antibiotic exposure and eczema up to age of 4 years, and 
also a positive but non-significant association with exposure 
during lactation period and recurrent wheeze [58]. Children 
recruited from the Copenhagen Prospective Study on Asthma 
in Childhood cohort had an increased risk of physician-diag-
nosed asthma and asthma exacerbations associated with ma-
terial use of antibiotics [59]. The most commonly prescribed 
antibiotic class was B-lactam penicillins, followed by sulfa-
methoxazole and trimethoprim, macrolides and others. There 
was no evidence that a particular antibiotic had higher risk of 
asthma. The risk of asthma at age of 5 years was independent 
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of the timing of maternal exposure to antibiotics for non-
respiratory infections. This confirmed that antibiotic use was 
not confounded by the maternal asthma phenotype or risk. 
The association of maternal antibiotic use and higher risk of 
cow’s milk allergy in infancy was demonstrated in a large, 
case-control study [60]. The prenatal use of cephalosporins, 
macrolides, tetracyclines, and broad-spectrum penicillins was 
associated with high risk of cow’s milk allergy and the high-
est association was noticed with cephalosporins. In addition, 
child’s use of antibiotics during the first month of life was 
also associated with an increased risk of cow’s milk allergy. 
This association seems to be contradicting with the case-
control, population study of early allergic sensitization in 
Lithuanian children [61] which showed that among multiple 
factors, maternal use of antibiotics had no significant impact 
on early atopic sensitization. A possible explanation for this 
contradiction that this latter study enrolled high percentage 
of children with high risk of allergy. In addition, other con-
founders such as socioeconomic factors, national habits and 
food were not considered. 
Neonatal Exposure
One of the common indications of broad-spectrum antibi-
otics in the first month of life is neonatal sepsis. A large 
questionnaire–based (ISAAC) population cohort on children 
(median age 12 years) showed an association between use 
and late childhood asthma and also higher risk of eczema 
[62]. Another, but small, case control retrospective study did 
not show any association between perinatal antibiotic expo-
sure and food allergy development [63]. The retrospective 
nature of the study, sample size, the urban based population 
and deficiency of data on genetic background of children and 
duration of breast feeding might have influenced the result.
Exposure by age of 6 months
Allergic disease such are quite common during infancy and 
early childhood. Research supports the association between 
antibiotic exposure by the age of 3 months and asthma and 
atopic sensitization [64]. Compared to no-antibiotic children, 
children who used antibiotics during the first 6 months of life 
did not show only high association of allergic diseases, they 
also demonstrated increased atopic sensitization as evidenced 
by skin prick tests and specific IgE [65]. Furthermore, strong 
association of antibiotic before 6 months and asthma and 
allergy (positive skin tests and IgE) was further confirmed 
and clearly shown that protopathic bias (antibiotic use was 
for respiratory non-asthma symptoms) had no role account 
for the main results (66). 
Exposure by age of 1 year
Several previous studies reported the association of antibi-
otic use during the first year of life and allergies. In UK, a 
large birth control (n=29,238 children) showed association 
of exposure by age of 1 year and dose-related development 
of asthma, eczema, and hay fever [67]. A large, longitudi-
nal birth cohort (n=13,116 children) showed antibiotic use 
by age of 1 year was significantly associated with asthma at 
age of 7 years [45]. This association was for non-respiratory 
tract infections and maximum in children who received more 
than 4 courses of antibiotics living in rural areas, with no 
maternal risk of asthma, and were not exposed to pets at 
time of birth. The last factors were also observed in other 
studies, make children most susceptible to antibiotic effects 
to develop asthma. This study confirmed the previous study 
on antibiotic use by age of 1 year and asthma, hay fever 
and eczema at age of 7-8 years [68]. In the same line, the 
simultaneous administration of paracetmol during the first 
year of life was associated with early wheeze (wheeze dur-
ing the first 2 years of life) and persistent wheeze but weak 
with late wheeze [69]. This demonstrates the importance of 
taking in consideration the different phenotypes of asthma 
or wheeze when evaluating this association. In studies that 
showed there was no association of antibiotic exposure and 
childhood asthma, one of the possible reasons for these re-
sults that the study did not take in account type of wheeze. 
This antibiotic use during infancy may not have an increase 
of risk of asthma or allergies during late childhood [70] (or 
adulthood [71]). 
Meanwhile, some studies reported that antibiotics exposure 
at age of 1 year is not association with asthma or atopic 
diseases such as the study on non-randomly selected chil-
dren living only in metropolitan area and had parental history 
of asthma or allergies [72]. In addition, asthma diagnosis is 
difficult before age of 5 years, and eczema diagnosis was 
uncertain (in this study), and statistical power of the study 
was limited [72]. 
Exposure between 2-15 Years
The use of broad spectrum antibiotics during the first 5 years 
of life is associated with high risk of allergies 2011 [73]. An 
elegant research on elementary school children indicated that 
there is interaction between IL-13 genotype (IL-13 character-
istically secreted by TH2 cells) and environmental factors, in-
cluding antibiotic use during infancy for more than 3 days 
leading to risk of allergic rhinitis [74]. 
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Exposure during Adulthood
Recently, it has been reported that the total serum IgE, allergy 
symptoms, and diagnosis of allergic diseases (including TH2 
predominance) were significantly higher in those who had 
antibiotics within 1 year of study compared to those who 
had antibiotics more than one year [75]. 
Amount of antibiotics and asthma risk
Studies on risk of asthma development and antibiotics also 
evaluated this risk in relation to number of antibiotic courses 
or total number of doses used during infancy. They compared 
no-courses versus 1-2, 3-4, and more than 4 courses of an-
tibiotics [38, 67-78]. The odd ratio of asthma development 
related to the number of courses of antibiotics taken in the 
first year of life was 1.16 (95% CI, 1.05 to 1.28) for each 
additional course of antibiotics (above one) [79]. This was 
determined by few studies to be more than 4 courses [59, 
67, 79]. The asthma risk was determined to be related to 
antibiotics doses in a dose-dependent manner (Fig. 2) [46]. 
Type of antibiotics and risk of asthma
Although some studies demonstrated that there was no asso-
ciation between asthma development and type of antibiotics 
used [80], several other studies demonstrated an association 
with specific type of antibiotics. However, the combinations 
of antibiotics varied in different studies. For example, Marra 
study [38] reported that penicillin, macrolides, cephalosporins 
and sulfonamide were associated with asthma development. 
It was also shown that amoxicillin, macrolides, cephalosporins 
and amoxicillin-clavulanic acid, but not penicillins were associ-
ated with asthma [67]. Other studies looked at risk of asthma 
and antibiotic coverage spectrum, that is narrow-spectrum 
antibiotics (penicillin, cloxacillin, cephalexin, cefadroxil, and 
erythromycin) versus broad-spectrum (other) antibiotics. Risk 
of asthma was higher with broad-spectrum antibiotics than 
narrow-spectrum antibiotics [45]. 
Conclusions
Early life exposure or use of antibiotics is associated with 
increased risk of allergic diseases particularly asthma. This 
effect is clearly evident during infancy and childhood, but 
becomes less evident in late childhood or adulthood. It seems 
that this risk is positively associated with total amount and 
type or spectrum of antibiotics used. There is increasing evi-
dence that antibiotics, as environmental factors, exert their 
maximal disruptive effect on beneficial gut commensals in 
low-risk children living in rural areas. The resulting alteration 
of the gut commensals drives the immature immune system 
of the infant towards allergic inflammation, and later devel-
opment of allergic diseases and asthma.
Taking in consideration the necessity to treat infections with 
appropriate antibiotics, the judicious use of antibiotics, par-
ticularly broad-spectrum antibiotics, in pregnant women and 
during early life exposure, might be of the cost-effective strat-
egies that could be adopted to reduce the possible risk of 
childhood asthma and allergies.
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